ArticleThe Journal of innovations in cardiac rhythm management2025
Functional Substrate Mapping of the Right Atrium: A Novel Method to Identify Critical Isthmus of Re-entry in Atrial Tachycardia.
Article in The Journal of innovations in cardiac rhythm management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Letter from the Editor in Chief.The Journal of innovations in cardiac rhythm management · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Right atrial tachycardia (AT) is a frequent rhythm disorder in patients with atrial scar mainly due to surgical incisions or congenital heart diseases. Despite the mounting evidence about AT mechanisms and types, data are scarce regarding the conduction properties as well as the functional characteristics of the atrial substrate during sinus rhythm, which plays a role in the maintenance of tachycardia. We sought to evaluate the relationship between the functional substrate mapping (FSM) characteristics of the right atrium (RA) and the critical isthmus (CI) of re-entrant ATs in patients with underlying atrial scar. Patients with a history of right AT who underwent catheter ablation with three-dimensional mapping were retrospectively enrolled. A voltage map and isochronal late activation map were created during the sinus/paced rhythm using multielectrode catheters to detect deceleration zones (DZs). Subsequently, AT was induced with programmed stimulation, and activation mapping was performed to detect the CI of the tachycardia. Atrial tachyarrhythmia (ATa) recurrence was defined as the detection of atrial fibrillation or AT (≥30 s) during follow-up. A total of 24 patients (mean age, 46 ± 15 years; 13 [54%] women) with right AT were included. A total of 36 ATs were mapped (16 [44.4%] localized re-entry, 20 [55.6%] macro-re-entry). Atrial low-voltage zones composed 23.3% ± 13.0% of the total RA. The mean values of bipolar voltage, electrogram duration, and conduction velocity during sinus rhythm corresponding to the CI of ATs were 0.18 ± 0.10 mV, 121.7 ± 29.4 ms, and 0.06 ± 0.04 m/s, respectively. The total number of DZs per chamber was 1.1 ± 0.3, with all being located in the low-voltage zone (<0.5 mV) detected by high-density mapping. All CIs of non-cavotricuspid isthmus (CTI)-dependent re-entry were co-localized with DZs detected during FSM. The positive predictive value of DZs to detect the CI of inducible ATs was 80.8%. During a mean follow-up of 11.7 ± 8.1 months, freedom from atrial tachyarrhythmias was 87.5%. Although CTI-dependent macro-re-entry is the most common mechanism in patients with RA scar, our findings demonstrated the relevance of FSM to predict non-CTI-dependent ATs. Conduction slowing manifested as DZs with continuous-fragmented signal morphology may guide ablation strategy tailoring in the case of underlying RA scar.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.